Effectiveness and cost-effectiveness of palliative care in natural experiments: a systematic review

被引:2
作者
Jiang, Jingjing [1 ]
Kim, Narae [2 ]
Garrido, Melissa M. [3 ,4 ]
Jacobson, Mireille [2 ]
Mockler, David [5 ]
May, Peter [1 ]
机构
[1] Trinity Coll Dublin, Ctr Hlth Policy & Management, Dublin, Ireland
[2] Univ Southern Calif, Leonard D Schaeffer Ctr Hlth Policy & Econ, Los Angeles, CA USA
[3] Boston VA Healthcare Syst, Partnered Evidence Based Policy Resource Ctr, Boston, MA USA
[4] Boston Univ, Sch Publ Hlth, Dept Hlth Law Policy & Management, Boston, MA USA
[5] Trinity Coll Dublin, Lib Trinity Coll Dublin, Dublin, Ireland
关键词
Service evaluation; Terminal care; Cancer; Chronic conditions; INSTRUMENTAL VARIABLES; HOSPICE CARE; IMPACT; EXPENDITURES; DIFFERENCE; OUTCOMES; PATIENT; GROWTH;
D O I
10.1136/spcare-2022-003993
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
ContextInvestigators in palliative care rely heavily on routinely collected data, which carry risk of unobserved confounding and selection bias. 'Natural experiments' offer opportunities to generate credible causal treatment effect estimates from observational data. ObjectivesWe aimed first to review studies that employed 'natural experiments' to evaluate palliative care, and second to consider implications for expanding use of these methods. MethodsWe searched systematically seven databases to identify studies using 'natural experiments' to evaluate palliative care's effect on outcomes and costs. We searched three grey literature repositories, and hand-searched journals and prior systematic reviews. We assessed reporting using the Strengthening the Reporting of Observational Studies in Epidemiology checklist and a bespoke methodological quality tool, using two reviewers at each stage. We combined results in a narrative synthesis. ResultsWe included 17 studies, which evaluated a wide range of interventions and populations. Seven studies employed a difference-in-differences design; five each used instrumental variables and interrupted time series analysis. Outcomes of interest related mostly to healthcare use. Reporting quality was variable. Most studies reported lower costs and improved outcomes associated with palliative care, but a third of utilisation and place of death evaluations found no effect. ConclusionAmong the large number of observational studies in palliative care, a small minority have employed causal mechanisms. High-volume routine data collection, the expansion of palliative care services worldwide and recent methodological advances offer potential for increased use of 'natural experiments'. Such studies would improve the quality of the evidence base.
引用
收藏
页码:e150 / e161
页数:12
相关论文
共 61 条
  • [1] Association of the Frequency of In-Home Care Services Utilization and the Probability of In-Home Death
    Abe, Kazuhiro
    Kawachi, Ichiro
    Watanabe, Taeko
    Tamiya, Nanako
    [J]. JAMA NETWORK OPEN, 2021, 4 (11) : e2132787
  • [2] Palliative care integration indicators: an European regional analysis
    Antonio Sanchez-Cardenas, Miguel
    Garralda, Eduardo
    Sofia Arias-Casais, Natalia
    Benitez Sastoque, Edgar Ricardo
    Van Steijn, Danny
    Moine, Sebastien
    Murray, Scott A.
    Centeno, Carlos
    [J]. BMJ SUPPORTIVE & PALLIATIVE CARE, 2021,
  • [3] Arias-Casais N., 2019, EAPC Atlas of Palliative Care in Europe 2019
  • [4] The effectiveness and cost-effectiveness of hospital-based specialist palliative care for adults with advanced illness and their caregivers
    Bajwah, Sabrina
    Oluyase, Adejoke O.
    Yi, Deokhee
    Gao, Wei
    Evans, Catherine J.
    Grande, Gunn
    Todd, Chris
    Costantini, Massimo
    Murtagh, Fliss E.
    Higginson, Irene J.
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2020, (09):
  • [5] Effects of Italian Smoking Regulation on Rates of Hospital Admission for Acute Coronary Events: A Country-Wide Study
    Barone-Adesi, Francesco
    Gasparrini, Antonio
    Vizzini, Loredana
    Merletti, Franco
    Richiardi, Lorenzo
    [J]. PLOS ONE, 2011, 6 (03):
  • [6] Comparison of Site of Death, Health Care Utilization, and Hospital Expenditures for Patients Dying With Cancer in 7 Developed Countries
    Bekelman, Justin E.
    Halpern, Scott D.
    Blankart, Carl Rudolf
    Bynum, Julie P.
    Cohen, Joachim
    Fowler, Robert
    Kaasa, Stein
    Kwietniewski, Lukas
    Melberg, Hans Olav
    Onwuteaka-Philipsen, Bregje
    Oosterveld-Vlug, Mariska
    Pring, Andrew
    Schreyoegg, Jonas
    Ulrich, Connie M.
    Verne, Julia
    Wunsch, Hannah
    Emanuel, Ezekiel J.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2016, 315 (03): : 272 - 283
  • [7] Interrupted time series regression for the evaluation of public health interventions: a tutorial
    Bernal, James Lopez
    Cummins, Steven
    Gasparrini, Antonio
    [J]. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 2017, 46 (01) : 348 - 355
  • [8] Economic evaluation and clinical trials: size matters - The need for greater power in cost analyses poses an ethical dilemma
    Briggs, A
    [J]. BRITISH MEDICAL JOURNAL, 2000, 321 (7273) : 1362 - 1363
  • [9] Instrumental variable methods in comparative safety and effectiveness research
    Brookhart, M. Alan
    Rassen, Jeremy A.
    Schneeweiss, Sebastian
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2010, 19 (06) : 537 - 554
  • [10] Development of a tool for defining and identifying the dying patient in hospital: Criteria for Screening and Triaging to Appropriate aLternative care (CriSTAL)
    Cardona-Morrell, Magnolia
    Hillman, Ken
    [J]. BMJ SUPPORTIVE & PALLIATIVE CARE, 2015, 5 (01) : 78 - 90